Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson's disease
Acta Neuropathol Commun (2025) 13 (1), 13 DOI: 10.1186/s40478-024-01923-8
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity
J Autoimmun (2025) 152, 103390 DOI: 10.1016/j.jaut.2025.103390
A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson’s disease
Sci Adv (2025) 11 (3), eado4927 DOI: 10.1126/sciadv.ado4927
Protein mimetic 2D FAST rescues alpha synuclein aggregation mediated early and post disease Parkinson’s phenotypes
Nat Commun (2024) 15 (1), 3658 DOI: 10.1038/s41467-024-47980-4
Human Microglia–Like Cells Differentiated from Monocytes with GM-CSF and IL-34 Show Phagocytosis of α-Synuclein Aggregates and C/EBPβ-Dependent Proinflammatory Activation
Mol Neurobiol (2024). https://doi.org/10.1007/s12035-024-04289-z
Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson’s Disease Diagnosis and Duration
Journal of Parkinson’s Disease. 2024;14(4):667-679. doi:10.3233/JPD-230390
Synthetic β-sheets mimicking fibrillar and oligomeric structures for evaluation of spectral X-ray scattering technique for biomarker quantification
Cell Biosci (2024) 14 (1), 26 DOI: 10.1186/s13578-024-01208-6
α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay
Ann Neurol (2024) 95 (6), 1173-1177 DOI: 10.1002/ana.26917
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Acta Neuropathol (2024) 147 (1), 14 DOI: 10.1007/s00401-023-02657-y
Nanoplastics exacerbate Parkinson's disease symptoms in C. elegans and human cells
J Hazard Mater (2024) 465, 133289 DOI: 10.1016/j.jhazmat.2023.133289